These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 33498041)
1. Clinical Characteristics, Molecular Features, and Long-Term Follow-Up of 15 Patients with Neonatal Diabetes: A Single-Centre Experience. Abali ZY; De Franco E; Karakilic Ozturan E; Poyrazoglu S; Bundak R; Bas F; Flanagan SE; Darendeliler F Horm Res Paediatr; 2020; 93(7-8):423-432. PubMed ID: 33498041 [TBL] [Abstract][Full Text] [Related]
2. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892 [TBL] [Abstract][Full Text] [Related]
3. Genetic characteristics, clinical spectrum, and incidence of neonatal diabetes in the Emirate of AbuDhabi, United Arab Emirates. Deeb A; Habeb A; Kaplan W; Attia S; Hadi S; Osman A; Al-Jubeh J; Flanagan S; DeFranco E; Ellard S Am J Med Genet A; 2016 Mar; 170(3):602-9. PubMed ID: 26463504 [TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations. Demirbilek H; Arya VB; Ozbek MN; Houghton JA; Baran RT; Akar M; Tekes S; Tuzun H; Mackay DJ; Flanagan SE; Hattersley AT; Ellard S; Hussain K Eur J Endocrinol; 2015 Jun; 172(6):697-705. PubMed ID: 25755231 [TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical heterogeneity of permanent neonatal diabetes mellitus: a single tertiary centre experience. Laimon W; El-Ziny M; El-Hawary A; Elsharkawy A; Salem NA; Aboelenin HM; Awad MH; Flanagan SE; De Franco E Acta Diabetol; 2021 Dec; 58(12):1689-1700. PubMed ID: 34426871 [TBL] [Abstract][Full Text] [Related]
6. Molecular and clinical features of K Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997 [TBL] [Abstract][Full Text] [Related]
7. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds. Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672 [TBL] [Abstract][Full Text] [Related]
8. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Polak M; Cavé H Orphanet J Rare Dis; 2007 Mar; 2():12. PubMed ID: 17349054 [TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea. Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029 [TBL] [Abstract][Full Text] [Related]
10. Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Kanakatti Shankar R; Pihoker C; Dolan LM; Standiford D; Badaru A; Dabelea D; Rodriguez B; Black MH; Imperatore G; Hattersley A; Ellard S; Gilliam LK; Pediatr Diabetes; 2013 May; 14(3):174-80. PubMed ID: 23050777 [TBL] [Abstract][Full Text] [Related]
11. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants. Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668 [TBL] [Abstract][Full Text] [Related]
13. Neonatal Diabetes: Two Cases with Isolated Pancreas Agenesis due to Homozygous PTF1A Enhancer Mutations and One with Developmental Delay, Epilepsy, and Neonatal Diabetes Syndrome due to KCNJ11 Mutation. Evliyaoğlu O; Ercan O; Ataoğlu E; Zübarioğlu Ü; Özcabı B; Dağdeviren A; Erdoğan H; De Franco E; Ellard S J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):168-174. PubMed ID: 28943513 [TBL] [Abstract][Full Text] [Related]
14. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China. Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793 [TBL] [Abstract][Full Text] [Related]
15. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]. Busiah K; Drunat S; Vaivre-Douret L; Bonnefond A; Simon A; Flechtner I; Gérard B; Pouvreau N; Elie C; Nimri R; De Vries L; Tubiana-Rufi N; Metz C; Bertrand AM; Nivot-Adamiak S; de Kerdanet M; Stuckens C; Jennane F; Souchon PF; Le Tallec C; Désirée C; Pereira S; Dechaume A; Robert JJ; Phillip M; Scharfmann R; Czernichow P; Froguel P; Vaxillaire M; Polak M; Cavé H; Lancet Diabetes Endocrinol; 2013 Nov; 1(3):199-207. PubMed ID: 24622368 [TBL] [Abstract][Full Text] [Related]
16. Genotype and Phenotype Heterogeneity in Neonatal Diabetes: A Single Centre Experience in Turkey. Denkboy Öngen Y; Eren E; Demirbaş Ö; Sobu E; Ellard S; De Franco E; Tarım Ö J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):80-87. PubMed ID: 32820876 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273 [TBL] [Abstract][Full Text] [Related]
18. Wolcott-Rallison syndrome in Iran: a common cause of neonatal diabetes. Asl SN; Vakili R; Vakili S; Soheilipour F; Hashemipour M; Ghahramani S; De Franco E; Yaghootkar H J Pediatr Endocrinol Metab; 2019 Jun; 32(6):607-613. PubMed ID: 31141482 [TBL] [Abstract][Full Text] [Related]
19. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children. Balamurugan K; Kavitha B; Yang Z; Mohan V; Radha V; Shyng SL Pediatr Diabetes; 2019 Jun; 20(4):397-407. PubMed ID: 30861254 [TBL] [Abstract][Full Text] [Related]
20. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation. Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]